@article{TaflerHerbertSchmidtetal.1993,
  author    = {Tafler, R. and Herbert, M. K. and Schmidt, R. F. and Weis, K. H.},
  title     = {Small reduction of capsaicin-induced neurogenic inflammation in human forearm skin by the glucocorticoid prednicarbate},
  series = {Agents Actions},
  volume    = {38},
  journal   = {Agents Actions},
  number    = {Special Conference Issue},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-127698},
  pages     = {C31-34},
  year      = {1993},
  abstract  = {No abstract available.},
  language  = {en}
}
@article{HerbertTaflerSchmidtetal.1993,
  author    = {Herbert, M. K. and Tafler, R. and Schmidt, R. F. and Weis, K. H.},
  title     = {Cyclooxygenase inhibitors acetylsalicylic acid and indomethacin do not affect capsaicin-induced neurogenic inflammation in human skin},
  series = {Agents Actions},
  volume    = {38},
  journal   = {Agents Actions},
  number    = {Special Conference Issue},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-127666},
  pages     = {C25-27},
  year      = {1993},
  abstract  = {Neurogenic inflammation is evoked by neuropeptides released from primary afferent terminals and, presumably, by other secondarily released inflammatory mediators. This study examines whether prostaglandins might participate in the development of neurogenic inflammation in humans and whether cyclooxygenase inhibitors have any anti-inflammatory effect on this type of inflammation. In healthy volunteers, neurogenic inflammation was elicited by epicutaneously applied capsaicin (1 \%), after systemic pretreatment with acetylsalicylic acid, or topically applied indomethacin compared to pretreatment with saline or vehicle, respectively. The extent of neurogenic inflammation was quantified by planimetry of visible flare size and recording the increase of superficial cutaneous blood flow (SCBF) with a laser Doppler flowmeter. Capsaicin-induced flare sizes and outside SCBF (both representing neurogenically evoked inflammation) were unaffected by acetylsalicylic acid or indomethacin. Only the capsaicin-induced increase; of inside SCBF was attenuated by local pretreatment with indomethacin, reflecting the participation of prostaglandins in the inflammatory response of those areas which were in direct contact with capsaicin.},
  language  = {en}
}
@article{BurnsGoldsteinNewgreenetal.2016,
  author    = {Burns, Alan J. and Goldstein, Allan M. and Newgreen, Donald F. and Stamp, Lincon and Sch{\"a}fer, Karl-Herbert and Metzger, Marco and Hotta, Ryo and Young, Heather M. and Andrews, Peter W. and Thapar, Nikhil and Belkind-Gerson, Jaime and Bondurand, Nadege and Bornstein, Joel C. and Chan, Wood Yee and Cheah, Kathryn and Gershon, Michael D. and Heuckeroth, Robert O. and Hofstra, Robert M.W. and Just, Lothar and Kapur, Raj P. and King, Sebastian K. and McCann, Conor J. and Nagy, Nandor and Ngan, Elly and Obermayr, Florian and Pachnis, Vassilis and Pasricha, Pankaj J. and Sham, Mai Har and Tam, Paul and Vanden Berghe, Pieter},
  title     = {White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies},
  series = {Developmental Biology},
  volume    = {417},
  journal   = {Developmental Biology},
  number    = {2},
  doi       = {10.1016/j.ydbio.2016.04.001},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-187415},
  pages     = {229-251},
  year      = {2016},
  abstract  = {Over the last 20 years, there has been increasing focus on the development of novel stem cell based therapies for the treatment of disorders and diseases affecting the enteric nervous system (ENS) of the gastrointestinal tract (so-called enteric neuropathies). Here, the idea is that ENS progenitor/stem cells could be transplanted into the gut wall to replace the damaged or absent neurons and glia of the ENS. This White Paper sets out experts' views on the commonly used methods and approaches to identify, isolate, purify, expand and optimize ENS stem cells, transplant them into the bowel, and assess transplant success, including restoration of gut function. We also highlight obstacles that must be overcome in order to progress from successful preclinical studies in animal models to ENS stem cell therapies in the clinic.},
  language  = {en}
}
@article{HerbertSchmidt1992,
  author    = {Herbert, M. K. and Schmidt, R. F.},
  title     = {Activation of normal and inflamed fine articular afferent units by serotonin},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59952},
  year      = {1992},
  abstract  = {In cats anesthetized with alpha-chloralose, extracellular recordings were made from fine afferent units belonging to the medial articular nerve (MAN) of the knee joint. The excitatory and sensitizing effects on articular afferents of serotonin (5-HT) applied intra-arterially close to the joint were examined. The joints were either normal or an experimental arthritis had been induced some hours before the recording session. Bolus injections of 1.35-135 p,g 5-HT excited about 43\% of group 111 (CV: 2.5-20 m/sec) and 73\% of group IV units (CV: < 2.5 mjsec) from normal joints. The latency was usually between 10 and 30 sec, and the duration and size of the responses were dose-dependent. Fast group 111 units (CV: > 16 mjsec) and group li units (CV: > 20 m/sec) were never excited by 5-HT. Repetitiveadministration led to pronounced tachyphylaxis of the 5-HT response. Inflammation induced an enhanced sensitivity of group III articular afferent units to close intra-arterial application of 5-HT. In particular the total duration of each response was considerably prolonged (4-10 min against 1-2 min under normal conditions). At the same time the tachyphylaxis seen under normal conditions was gteatly reduced. In contrast, group IV articular afferent units did not become sensitized to 5-HT in the course of inflammation. In normal joints 5-HT did not sensitize fineafferent units for movement-induced responses. However, after inflammation, a distinct sensitization to such movements by 5-HT application could be observed bothin group 111 and group IV fiber ranges. The sensitization had a short time course not exceeding 7 min. The tonic component of the movement-induced response was more enhanced than the phasic one. The bolus application of 5-HT led to temporary vasoconstriction of the knee joint vessels. This vasoconstriction was especially pronounced in inflamed joints and impeded the access of subsequently applied substances to the terminal regions of the afferent units under observation. lt is concluded that the present results support the notion that 5-HT may participate in the mediation of pain from inflamed tissue such as an arthritic joint by exciting and sensitizing fine afferent units. During inflammation group 111 units are particularly sensitive to 5-HT and, thus, may carry the bulk of the 5-HT-induced nociceptive messages.},
  subject      = {Medizin},
  language  = {en}
}
@article{HerbertHolzer1994,
  author    = {Herbert, M. K. and Holzer, P.},
  title     = {Nitric oxide mediates the amplification by interleukin-1β of neurogenic vasodilatation in the rat skin},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59969},
  year      = {1994},
  abstract  = {No abstract available.},
  subject      = {Medizin},
  language  = {en}
}
@article{HerbertHolzer1994,
  author    = {Herbert, M. K. and Holzer, P.},
  title     = {Interleukin-1ß enhances capsaicin-induced neurogenic vasodilatation in the rat skin},
  series = {British Journal of Pharmacology},
  volume    = {111},
  journal   = {British Journal of Pharmacology},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-128171},
  pages     = {681-686},
  year      = {1994},
  abstract  = {No abstract available.},
  language  = {en}
}
@incollection{Herbert1994,
  author    = {Herbert, M. K.},
  title     = {Analgetikaeinsatz beim geriatrischen Patienten},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-78001},
  publisher      = {Universit{\"a}t W{\"u}rzburg},
  year      = {1994},
  abstract  = {Nicht nur bei traumatologischen, sondern auch bei vielen internistischen und neurologischen Notf{\"a}llen ist der Schmerz das oder eines der Leitsymptome. Neben der Wiederherstellung und Sicherung der Vitalfunktionen ist die rasche und effiziente Schmerzlinderung eine der wichtigsten Aufgaben des Notarztes. Eine erfolgreiche analgetische Therapie verbessert zum einen die subjektive Befindlichkeit des Patienten und unterbricht zum anderen die durch starke Schmerzen initiierten und unterhaltenen sympathiko-adrenergen und metabolisch-endokrinen Streßreaktionen, mit all ihren nachteiligen Auswirkungen auf die H{\"a}modynamik und Respiration. Letzteres ist eine wichtige, positive Wirkung einer guten analgetischen Therapie, insbesondere beim kranken geriatrischen Patienten, der in den Kompensationsm{\"o}glichkeiten einzelner Organsysteme oft deutlich eingeschr{\"a}nkt ist. L{\"a}nger fortbestehende starke Schmerzen w{\"u}rden gerade bei diesen Patienten eine Einschr{\"a}nkung der H{\"a}modynamik und Respiration perpetuieren.},
  subject      = {Medizin},
  language  = {de}
}
@article{HerbertWoeckelKreienbergetal.2021,
  author    = {Herbert, S. L. and W{\"o}ckel, A. and Kreienberg, R. and K{\"u}hn, T. and Flock, F. and Felberbaum, R. and Janni, W. and Curtaz, C. and Kiesel, M. and St{\"u}ber, T. and Diessner, J. and Salmen, J. and Schwentner, L. and Fink, V. and Bekes, I. and Leinert, E. and Lato, K. and Polasik, A. and Schochter, F. and Singer, S.},
  title     = {To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?},
  series = {Breast Cancer Research and Treatment},
  volume    = {185},
  journal   = {Breast Cancer Research and Treatment},
  organization    = {BRENDA study group},
  issn      = {0167-6806},
  doi       = {10.1007/s10549-020-05974-y},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-232356},
  pages     = {677-684},
  year      = {2021},
  abstract  = {Objective In this study, we investigated to which extent patients feel well informed about their disease and treatment, which areas they wish more or less information and which variables are associated with a need for information about the disease, medical tests and treatment. Methods In a German multi-centre prospective study, we enrolled 759 female breast cancer patients at the time of cancer diagnosis (baseline). Data on information were captured at 5 years after diagnosis with the European Organisation for Research and Treatment of Cancer (EORTC) Information Module (EORTC QLQ-INFO24). Good information predictors were analysed using linear regression models. Results There were 456 patients who participated at the 5-year follow-up. They reported to feel well informed about medical tests (mean score 78.5) and the disease itself (69.3) but relatively poorly about other services (44.3) and about different places of care (31.3). The survivors expressed a need for more information concerning: side effects and long-term consequences of therapy, more information in general, information about aftercare, prognosis, complementary medicine, disease and therapy. Patients with higher incomes were better informed about medical tests (β 0.26, p 0.04) and worse informed with increasing levels of fear of treatment (β - 0.11, p 0.02). Information about treatment was reported to be worse by survivors > 70 years old (β -0.34, p 0.03) and by immigrants (β -0.11, p 0.02). Survivors who had received additional written information felt better informed about disease, medical tests, treatment and other services (β 0.19/0.19/0.20/0.25; each p < 0.01). Conclusion Health care providers have to reconsider how and what kind of information they provide. Providing written information, in addition to oral information, may improve meeting those information needs.},
  language  = {en}
}